← Alle mensen

JD

Judit Demeter

2 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Alisertib versus investigator's choice bij recidief/refractair perifeer T-cellymfoom: fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 maart 2019

Obinutuzumab versus rituximab plus CHOP bij onbehandeld DLBCL: GOYA fase III-studie

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 november 2017